Filter Results

Clear All Filters

Displaying 7 results for

GO
Search Filters: Population Health and Prevention cancel Maggie Davis cancel Beth Giambrone cancel

2022 Legislative Session Update: Part Two

Blog,
STIs,
HIV,
PFAS,

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

Public Health Policy Issues to Watch in 2021

Blog,
STIs,
HIV,
PFAS,

With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...

State and Territorial Caregiver Wellness Policies May Reduce Adverse Childhood Experiences

Blog,
ACEs,
Guam,

People exposed to adverse childhood experiences are at risk for negative physical and/or mental health outcomes, substance use disorders, and unfavorable social outcomes in adulthood. One known risk factor for ACEs is caregiver stress, ...

States Stepping Up to Support Families and Reduce Adverse Childhood Experiences

Blog,
ACEs,

Research confirms that strengthening economic supports can improve parental mental health, children’s health, education, and social outcomes.

ASTHO's 2024 Legislative Session Update: Part Two

Blog,
Utah,

ASTHO's 2024 Legislative Session Update: Part Two Beth Giambrone, Maggie Davis, Christina Severin ASTHO's Public Health Legislative Update on Tobacco, Mental Health, Environmental Health, Workforce, and Containing Infectious ...

ASTHO Policy Watch 2022: Health Equity and Rural Health

Blog,

ASTHO has identified health equity and rural health as issues that policymakers across the country will consider in 2022.

2023 Legislative Session Update: Part One

Blog,
STIs,
HIV,
PFAS,
Guam,
Utah,

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.